These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 35349481)
1. Specific human endogenous retroviruses predict metastatic potential in uveal melanoma. Bendall ML; Francis JH; Shoushtari AN; Nixon DF JCI Insight; 2022 May; 7(9):. PubMed ID: 35349481 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort. Lamas NJ; Lassalle S; Martel A; Nahon-Estève S; Macocco A; Zahaf K; Lalvee S; Fayada J; Lespinet-Fabre V; Bordone O; Pedeutour F; Baillif S; Hofman P Pathology; 2023 Dec; 55(7):929-944. PubMed ID: 37863710 [TBL] [Abstract][Full Text] [Related]
3. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma. Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663 [TBL] [Abstract][Full Text] [Related]
4. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations. Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373 [TBL] [Abstract][Full Text] [Related]
5. Human endogenous retroviruses and cancer prevention: evidence and prospects. Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240 [TBL] [Abstract][Full Text] [Related]
6. Recent approaches for the treatment of uveal melanoma: Opportunities and challenges. Khan SA; Almalki WH; Arora S; Kesharwani P Crit Rev Oncol Hematol; 2024 Jan; 193():104218. PubMed ID: 38040071 [TBL] [Abstract][Full Text] [Related]
7. A New Insight on Activation of Human Endogenous Retroviruses (HERVs) in Malignant Melanoma upon Exposure to CuSO4. Karimi A; Sheervalilou R; Kahroba H Biol Trace Elem Res; 2019 Sep; 191(1):70-74. PubMed ID: 30539386 [TBL] [Abstract][Full Text] [Related]
8. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis. Wang J; Liu M; Sun J; Zhang Z J Cancer Res Clin Oncol; 2024 Jan; 150(1):23. PubMed ID: 38246894 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic regulation of HERV activation in tumors and implications for translational research in oncology. Cherkasova EA; Chen L; Childs RW Front Cell Infect Microbiol; 2024; 14():1358470. PubMed ID: 38379771 [TBL] [Abstract][Full Text] [Related]
10. New immunotherapy approaches as the most effective treatment for uveal melanoma. Eteghadi A; Ebrahimi M; Keshel SH Crit Rev Oncol Hematol; 2024 Feb; 194():104260. PubMed ID: 38199429 [TBL] [Abstract][Full Text] [Related]
11. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. Qin Y; Bollin K; de Macedo MP; Carapeto F; Kim KB; Roszik J; Wani KM; Reuben A; Reddy ST; Williams MD; Tetzlaff MT; Wang WL; Gombos DS; Esmaeli B; Lazar AJ; Hwu P; Patel SP J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203661 [TBL] [Abstract][Full Text] [Related]
12. Liver metastasis in uveal melanoma - treatment options and clinical outcome. Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015 [TBL] [Abstract][Full Text] [Related]
13. Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers. Saini SK; Ørskov AD; Bjerregaard AM; Unnikrishnan A; Holmberg-Thydén S; Borch A; Jensen KV; Anande G; Bentzen AK; Marquard AM; Tamhane T; Treppendahl MB; Gang AO; Dufva IH; Szallasi Z; Ternette N; Pedersen AG; Eklund AC; Pimanda J; Grønbæk K; Hadrup SR Nat Commun; 2020 Nov; 11(1):5660. PubMed ID: 33168830 [TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Molecular and Genetic Research on Uveal Melanoma. Fuentes-Rodriguez A; Mitchell A; Guérin SL; Landreville S Cells; 2024 Jun; 13(12):. PubMed ID: 38920653 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in uveal melanoma treatment. Álvarez-Rodríguez B; Latorre A; Posch C; Somoza Á Med Res Rev; 2017 Nov; 37(6):1350-1372. PubMed ID: 28759124 [TBL] [Abstract][Full Text] [Related]
16. The role of endogenous retroviruses-K in human cancer. Salavatiha Z; Soleimani-Jelodar R; Jalilvand S Rev Med Virol; 2020 Nov; 30(6):1-13. PubMed ID: 32734655 [TBL] [Abstract][Full Text] [Related]
18. Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. Hahn S; Ugurel S; Hanschmann KM; Strobel H; Tondera C; Schadendorf D; Löwer J; Löwer R AIDS Res Hum Retroviruses; 2008 May; 24(5):717-23. PubMed ID: 18462078 [TBL] [Abstract][Full Text] [Related]
19. An update on inflammation in uveal melanoma. Liau S; Wang JZ; Zagarella E; Paulus P; Dang NHQH; Rawling T; Murray M; Zhou F Biochimie; 2023 Sep; 212():114-122. PubMed ID: 37105300 [TBL] [Abstract][Full Text] [Related]
20. Contribution of Human Retroviruses to Disease Development-A Focus on the HIV- and HERV-Cancer Relationships and Treatment Strategies. Liu CH; Grandi N; Palanivelu L; Tramontano E; Lin LT Viruses; 2020 Aug; 12(8):. PubMed ID: 32759845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]